Background-Routine clinical use of novel free-breathing, motion-corrected, averaged late-gadolinium-enhancement (moco-LGE) cardiovascular MR may have advantages over conventional breath-held LGE (bh-LGE), especially in vulnerable patients. Methods and Results-In 390 consecutive patients, we collected bh-LGE and moco-LGE with identical image matrix parameters. In 41 patients, bh-LGE was abandoned because of image quality issues, including 10 with myocardial infarction. When both were acquired, myocardial infarction detection was similar (McNemar test, P=0.4) with high agreement (κ=0.95). With artifact-free bh-LGE images, pixelwise myocardial infarction measures correlated highly (R 2 =0.96) without bias. Moco-LGE was faster, and image quality and diagnostic confidence were higher on blinded review (P<0.001 for all). During a median of 1.2 years, 20 heart failure hospitalizations and 18 deaths occurred. For bh-
N ovel free-breathing, motion-corrected, averaged cardiovascular MR (CMR) with late gadolinium enhancement (LGE) 1 for the detection and quantification of myocardial infarction (MI) and scar introduces several important advantages for routine clinical use. This technique is a key component of an emerging free-breathing CMR paradigm 1-5 that liberates patients and clinicians from significant constraints. Conceptually, without a mandate for breath holding or even sinus rhythm, free-breathing CMR scanning may be (1) less taxing to the patient and technologist who otherwise must coordinate their efforts; (2) more efficient, given the absence of delays between breath holds or repeated acquisitions, which are pronounced with frail patients; (3) more robust diagnostically, yielding high image quality with higher signal-to-noise ratios (SNRs; averaging) and freedom from ghosting artifacts (common in breath-held [bh] acquisitions); 1 and (4) more consistent and generalizable, extending these capabilities to more vulnerable patients with dyspnea, arrhythmia, and other comorbidity who can be challenging to image. Imaging vulnerable patients is especially important because MI is more prevalent in such patients: those who are older, those with heart failure, and those with atrial fibrillation-groups who may be unable to breath hold adequately. Thus, the free-breathing CMR paradigm for LGE may represent an important advance in CMR worthy of further study.
Clinical Perspective on p 432
CMR must provide robust LGE capability for all patients referred for CMR because subclinical disease is common. Indeed, the burden of MI in the general population is considerably higher than previously appreciated, given the high prevalence of clinically unrecognized MI detected by LGE that is prognostically adverse. [6] [7] [8] [9] LGE for detecting MI has been validated and predicts adverse events in large populations. 6, [10] [11] [12] [13] [14] [15] [16] [17] [18] Yet, prior studies suggested limitations associated with free-breathing single-shot subsecond LGE compared with conventional segmented bh-LGE, [19] [20] [21] highlighting a need for further improvement in free-breathing techniques to detect MI. 22 Subsequent innovation has introduced fully automated in-plane motion correction (with nonrigid deformation) to coregister a series of higher-spatial-resolution single-shot images followed by averaging to increase SNRs. 1, 22 This methodology yields consistently high-quality LGE images. 1, 22 To investigate the clinical performance of respiratory motion-corrected, free-breathing averaged LGE (moco-LGE), we compared it against conventional segmented bh-LGE acquired contemporaneously for a consecutive series of patients referred for CMR. We hypothesized that (1) blinded image quality and diagnostic confidence assessments would be superior for moco-LGE; (2) acquisition times would be shorter for moco-LGE; (3) pixelwise quantitative assessments of MI size would correlate highly without bias compared with high-quality bh-LGE images that were free of artifacts; (4) with blinded interpretation in a series of consecutive patients undergoing CMR, moco-LGE would detect a similar proportion of MI in the cohort as bh-LGE; and (5) moco-LGE would predict adverse events similarly to bh-LGE. Collectively, these efficacy data (infarct size comparisons) and effectiveness data (image quality/confidence ratings and outcomes predictions in a real-life clinical practice setting) may advance our acceptance and understanding of moco-LGE and the merits of the free-breathing CMR paradigm.
Methods

Patient Population
After institutional review board approval was granted, we prospectively recruited 390 adult patients referred for clinical CMR with contrast at the University of Pittsburgh Medical Center CMR Center at the time of their CMR scan from April 18 to November 18, 2011, and followed them up through November 10, 2012. This cohort was formed a priori to examine whether novel LGE techniques were diagnostically robust and predicted patient outcomes. Inclusion criteria were written informed consent and completion of a contrast-enhanced CMR scan, which required a glomerular filtration rate of ≥30 mL/ min per 1.7 m 2 , and no other contraindications to CMR. Comorbidity data were determined according to the medical record acquired at the time of CMR scanning and informed consent. Study data were managed using REDCap (Research Electronic Data Capture) electronic data capture tools hosted at the University of Pittsburgh. 23 Vital status was ascertained by Social Security Death Index queries and medical record review. Hospitalizations for heart failure were identified by electronic chart review of University of Pittsburgh Medical Center records. There were no exclusion criteria. Our clinical practice is to accept referrals regardless of frailty.
CMR Scans
All patients received clinical CMR scans by 2 dedicated CMR technologists with a 1.5-T Siemens Magnetom Espree (Siemens Medical Solutions, Erlangen, Germany) and a 32-channel phased-array cardiovascular coil. The examination included standard bh-segmented cine imaging with steady-state free precession in the short axis (6mm slice thickness with 4-mm gap) and 2-, 3-, and 4-chamber orientations (image matrix, 256×≈144; acceleration factor [GRAPPA], 3). When patients could not hold their breath or had significant arrhythmia, we used real-time cine imaging (image matrix, 256×≈96; acceleration factor [GRAPPA], 4).
Conventional LGE
bh-LGE imaging with segmented fast low-angle shot gradient echo readouts was performed 10 minutes after a 0.2-mmol/kg intravenous gadoteridol bolus (Prohance; Bracco Diagnostics, Princeton, NJ). To optimize LGE, we used a phase-sensitive inversion recovery pulse sequence to increase SNRs, to correct for surface coil intensity variation, and to render signal intensity proportional to T1 recovery. 24 This sequence acquires inversion recovery-and proton density-weighted data every other heartbeat (with every third heartbeat for faster heart rates >100 bpm). Phase-sensitive inversion recovery yields constant infarct size during a variety of inversion times, 24 and LGE yields constant infarct size measures between 10 and 30 minutes after contrast. 25 Typical parameters included an adiabatic 180° inversion pulse every second R-R, field of view of 38×32 cm, matrix of 256×144 (typical phase matrix range, 128-160) with lower phase matrix for faster heart rates (eg, 128 bpm), 6-mm slice thickness with 4-mm gap for short-axis stacks, repetition time/echo time of 8.3/3.2 milliseconds, FLASH flip angle of 25°, 20 views per segment, inversion time of ≈300 millilseconds (adjusted for nulling noninfarcted myocardium), pixel bandwidth of 140 Hz, and acceleration factor (GRAPPA) of 2. Typical breath holds were 10 heartbeats in duration, including discarded beats to ensure steady state.
Free-Breathing Moco-LGE
After acquisition of bh-LGE images, respiratory motion-corrected, free-breathing single-shot steady-state free-precession, averaged phase-sensitive inversion recovery images (moco-LGE) 1 were acquired with identical spatial resolution, field of view, slice thickness, and slice location as the conventional bh-segmented FLASH LGE images with optimized inversion time for nulling. Typical steadystate free-precession readout parameters were echo time of 1.65 milliseconds, pixel bandwidth of 977 Hz, acceleration factor (GRAPPA) of 2, and flip angle of 50°. Each acquisition had 8 repeated measurements per slice with each measurement every second R-R interval (every third for faster heart rates >100 bpm) during a duration of 16 heartbeats (or 24 heartbeats for faster heart rates >100 bpm). Fully automated in-plane respiratory motion compensation was achieved by performing independent nonrigid registration processes to a reference frame with respect to all the other frames in the complete set of acquired images. Each independent registration step implemented an optimization procedure that minimizes a similarity measure of the 2 images to find the best transformation that maps a given frame into the frame of reference described previously, 1 a process representing an image-based navigator scheme.
The averaged image resulting from averaging of the most similar 4 of the 8 (ie, 50%) single-shot images provided the most reliable image quality because inclusion of all 8 single-shot images (100%) might introduce uncompensated through-plane motion. The moco-LGE technique corrects in-plane motion only and cannot correct for through-plane motion. Averaging 4 images doubles SNR, where SNR improvement=square root (number of averages). 1
Image Analysis
We examined separate blinded image analyses to compare moco-LGE and bh-LGE on the basis of (1) pixelwise infarct size measures, (2) acquisition time, (3) image quality scores, (4) image confidence scores, and (5) ability to stratify risk of subsequent outcomes in the full cohort of consecutive patients. We had no histological gold standard in this clinical cohort and did not use the clinical report for analysis, which may have been influenced by either bh-LGE or moco-LGE. Acquisition times for short-axis LGE stacks were obtained from the time stamps on the first and last images of the stack. MI was identified when LGE involved the subendocardium in a coronary distribution; other atypical patterns of LGE were specifically not designated as MI. This strategy yields sensitivities and specificities of >90% for MI detection. 6, 13, [26] [27] [28] Among 41 individuals with high image quality on bh-LGE images that were otherwise chosen arbitrarily, we quantified infarct size from short-axis stacks of LGE images, in which there is minimal through-plane motion. 1 Computer-assisted planimetry using Medis QMass software (version 7.2, Leiden, the Netherlands) quantified MI mass (blinded) using the full width at half-maximum technique, an accepted technique for LGE quantification. 29 We used subjective image quality ratings blinded to clinical interpretation and outcomes. Similar to Sievers et al, 20 we rated image quality (1=very poor and not analyzable, 2=poor, 3=acceptable, 4=good, and 5=very good) and rated the degree of observer confidence with regard to the presence or the absence of infarction (1=low confidence, 2=some confidence, and 3=high confidence). Images were interpreted by 3 experienced observers blinded to clinical status and to the observers' interpretation of the corresponding moco-LGE or bh-LGE image, performed on different days. The bh-LGE and moco-LGE images each have their own identifiable characteristics because the artifact type (chest wall ghosting), noise levels, and contrast between different chemical species (blood, myocardium, fat, etc) make it easy for the experienced observer to distinguish the LGE pulse sequence. Therefore, we made no attempt to blind observers to the LGE technique.
Statistical Analysis
Categorical variables were summarized as percentages, and continuous variables were summarized as median with first and third 
Results
Patient Characteristics
The characteristics of the sample are summarized in Table 1 according to whether or not MI was recorded in the clinical report. Overall, 20% (77 of 390) of the sample exhibited MI on LGE images according to the clinical report. Both bh-LGE and moco-LGE images were available to the physician responsible for the scan. No adverse events occurred.
Free-Breathing, Moco-LGE Versus bh-LGE
Examples of good LGE image quality for bh-LGE and moco-LGE acquisitions are shown in Figure 1 moco-LGE (100%; P<0.001), including 10 with MI. An example of a case in which bh-LGE was not performed is shown in Figure 3 ; moco-LGE data yielded exactly opposite results compared with noninvasive testing, culminating in excellent patient outcome with near-complete recovery of left ventricular function that was profoundly dysfunctional at baseline. A history of atrial fibrillation was associated with higher odds of fair image quality by moco-LGE (odds ratio, 8.6; 95% CI, 2.45-30.0) and nonacquisition of bh-LGE (odds ratio, 5.81; 95% CI, 1.99-16.9). We examined acquisition times in a subset of 100 consecutive patients from September 26, 2011, to November 18, 2011, who had bh-LGE acquired. Free-breathing, moco-LGE was significantly faster than bh-LGE (median, 160 seconds [Q1-Q3, 139-182 seconds] versus 331 seconds [Q1-Q3, 291-359 seconds]; P<0.001) as shown in Figure 4 . Free-breathing, moco-LGE yielded higher image quality than bh-LGE on the basis of the rating schemes when both types of images were acquired (Table 2) . Similarly, moco-LGE provided higher diagnostic confidence (online-only Data Supplement) than bh-LGE on the basis of the rating schemes. These findings were consistent across all 3 observers.
There was excellent agreement between moco-LGE and bh-LGE for detecting MI, with only 6 cases (1.7%) among 347 pairs of moco-LGE and bh-LGE images yielding disagreement on blinded review. In 4 individuals, MI was noted only on bh-LGE, and in 2 individuals, MI was noted only on moco-LGE. The extent of disagreement was not significant (McNemar test, P=0.41). The Cohen Κ statistic was 0.95 (95% CI, 0.90-0.99), revealing high agreement.
Quantitative MI size measurements on a subset of 41 patients with excellent bh-LGE image quality showed nearly identical values compared with quantitative MI size measurements from moco-LGE images across the MI size spectrum ( Figure 5 ). The correlation was high, with the regression line approximating the unity line with a slope of nearly 1.0 and a γ intercept of nearly zero. Bland-Altman plots revealed excellent agreement across the MI size spectrum ( Figure 5 ).
Survival Analysis
During a median follow-up of 1.2 years (Q1-Q3, 1.1-1.4 years), there were 36 total events: 18 hospitalizations for heart failure in which 2 patients died and 16 additional deaths. Lower image quality and nonacquisition for bh-LGE were related to increased patient vulnerability as confirmed by their outcomes (log-rank P<0.001) as shown in Figure 6 ; those who did not receive bh-LGE were a particularly vulnerable group (10 events among the 41). There remained a significant association between vulnerability determines by adverse outcomes and lower image quality for bh-LGE when (1) we conservatively recoded missing bh-LGE data as 3=acceptable (hazard ratio [HR], 2.90; 95% CI, 1.57-5.34 for every decrement in image quality) or (2) we ignored the 41 patients without bh-LGE (HR, 2.18; 95% CI, 1.01-4.71 for every decrement). Similar trends were observed for observer confidence when missing data for bh-LGE were ignored (HR, 2.58; 95% CI, 0.97-6.84 for every decrement) or recoded as 1=low confidence (HR, 2.03; 95% CI, 1.41-2.93 for every decrement) or 2=some confidence (HR, 3.38; 95% CI, 1.74-6.57 for every decrement).
There were no such relationships for moco-LGE ( Figure 6 ); moco-LGE image quality was not related to outcomes (HR, 1.08; 95% CI, 0.52-2.26 for every decrement), and there was no association between moco-LGE observer confidence and outcomes (HR, 0.47; 95% CI, 0.06-3.40 for every decrement). The moco-LGE technique was able to stratify risk significantly in the full cohort (log-rank P=0.01), but the bh-LGE technique was not (log-rank P=0.056) because a significant number of vulnerable individuals did not receive bh-LGE ( Figure 6 ). Survival analysis results did not change significantly with the exclusion of 64 survivors (16%) who may not have been followed up at our institution.
Figure 2.
In the setting or arrhythmia or inability to breath hold, free-breathing motion-corrected late gadolinium enhancement (moco-LGE) can offer improved image quality compared with breath-held late gadolinium enhancement (bh-LGE) images. F, The patient had no structural heart disease but did exhibit respiratory motion artifact from chest wall ghosting mimicking midwall fibrosis on the bh-LGE image that was not present on adjacent slices or moco-LGE images.
Discussion
This study used moco-LGE to investigate the free-breathing paradigm for LGE in a consecutive cohort of 390 patients referred for clinical CMR. The principal findings of our study were that free-breathing, moco-LGE outperformed conventional segmented bh-LGE in terms of acquisition time, image quality, diagnostic confidence, and number of patients in whom high-quality LGE could be acquired with clinician confidence. These characteristics extend LGE-based risk stratification to include patients with vulnerability confirmed by increased mortality and incident heart failure hospitalization. These vulnerable patients were challenging to image successfully with bh-LGE. Indeed, patients in whom bh-LGE was abandoned or suboptimal . We present a case in which breath-held late gadolinium enhancement (bh-LGE) was not acquired because of atrial fibrillation and inability to breath hold, and motion-corrected late gadolinium enhancement (moco-LGE) revealed opposite results compared with other noninvasive modalities on 3 critical parameters: ischemia, myocardial infarction (MI), and mural thrombus. A functional 90-year-old patient had chest discomfort and peak troponins of 4.44 ng/mL. Regadenoson single-photon emitted computed tomography (SPECT) revealed no ischemia and a moderate-sized MI without apparent viability in the left anterior descending (LAD) artery distribution with an apical aneurysm (A). Echocardiography also revealed wall motion abnormality in the LAD artery distribution and a probable mural thrombus (B). Entirely free-breathing cardiovascular MR (CMR) also revealed akinetic/aneurysmal wall motion in the LAD distribution. Yet, in contrast to the echocardiogram, no thrombus was observed. In contrast to SPECT, no MI was observed in the anterior and anteroseptal walls, rated as entirely viable (C and D) with moco-LGE. Given the wall motion abnormality, preserved viability, and lack of history to support stress cardiomyopathy, cardiac catheterization was recommended. We suspected proximal LAD disease with profoundly ischemic stunned or hibernating myocardium, despite the SPECT examination. On the basis of the moco-LGE data and prior data, 30 we predicted full functional recovery if revascularization was feasible. At catheterization, a 90% LAD lesion supplying a large amount of myocardium was stented, restoring luminal patency; the procedure was complicated by a small left main dissection. The patient returned for CMR 3 months later; cines exhibited full functional recovery, confirming initial LAD territory viability claims by CMR (C and D). A tiny apical wall motion abnormality persisted (asterisk; E and F). One year later, this patient enjoys a high quality of life without any cardiac complaints or events (see online-only Data Supplement for additional case data).
were the patients most prone to adverse outcomes. The moco-LGE technique yielded similar quantitative MI size measures compared with artifact-free bh-LGE across the MI size spectrum without evidence of bias. Also, moco-LGE and bh-LGE did not exhibit significant differences in the diagnosis of MI when bh-LGE could be acquired. These efficacy data (infarct size comparisons) and effectiveness data (relationship between image quality/confidence ratings and outcomes in a clinical practice setting) suggest moco-LGE is robust.
Our study illustrates a fundamental limitation of breathholding techniques: They fail to bring the advantages of CMR to all referred patients. Image quality and diagnostic confidence for bh-LGE were associated with outcomes, whereby those with worse images were the most vulnerable as demonstrated by their event rates. These data suggest that breath-holding techniques struggle in the most vulnerable patients in whom the need for robust characterization is the highest. This observation did not apply to moco-LGE, which highlights a critical advantage of the free-breathing paradigm: Patient vulnerability does not seem to compromise image quality. Therefore, we highlight a potential need for vendors to develop free-breathing techniques for all CMR pulse sequences to bring the advantages of CMR to all patients.
Given the inherent importance of detecting MI with LGE, [6] [7] [8] [9] [10] [11] including the large burden of unrecognized MI in the community, 6 these data have important implications for CMR practice. On the basis of our results and our clinical experience, we believe moco-LGE is ready for routine clinical use, perhaps as the primary LGE technique. Further study of the clinical performance of moco-LGE would be useful to confirm its clinical utility.
Our data differ from the findings of Sievers et al, 21 who reported inferior performance when free-breathing techniques were used with a single measurement at lower spatial resolution (eg, 104×192). The main difference in our methodology was (1) enforcement of higher spatial resolution for moco-LGE, identical to bh-LGE, and (2) the application of novel motion correction and averaging techniques to increase SNRs from averaging of automatically coregistered images that used image-based navigators. The improvement in SNRs with moco-LGE and the lack of ghosting artifacts are clinically important advantages that we believe significantly improve reader confidence. The beneficial effects of averaging motion-corrected images are an important technical advance in CMR that may not yet be widely appreciated by the CMR community. The ranking of image similarity measures is also an important advantage to minimize effects of through-plane motion, especially in long-axis image orientations, because through-plane motion will diminish image similarity. To minimize the breath hold, our bh-LGE protocol used parallel imaging. Omitting parallel imaging would only prolong the breath hold, worsen motion artifacts, and strengthen the case for moco-LGE.
Limitations
Our study has limitations. First, our data are from a singlecenter referral population, so results may not generalize. We enrolled consecutive patients to minimize this limitation. Second, the order of bh-LGE and moco-LGE was not randomized, so delayed washout may have favored moco-LGE with enhanced blood pool-MI contrast. We believe the differences are minor, especially because LGE is reproducible between 10 and 30 minutes with minimal changes in the partition coefficient. Third, some bh-LGE imaging attempts were abandoned by the clinician in charge of the clinical study (breaching the study protocol), so comparison of image quality (efficacy) could not be performed for these patients. Still, our data from a purely clinical population may better reflect expected clinical practice (effectiveness). Poor outcomes in those in whom bh-LGE was abandoned suggest underlying frailty and less ability to execute breath holding successfully. Fourth, the futility of blinding of the bh-LGE and moco-LGE techniques made it impossible to exclude bias corrupting of image quality ratings that were blinded to all other clinical data. We used multiple observers and examined multiple aspects of LGE performance, including pixelwise MI size assessments, to minimize this bias.
Conclusions
The efficacy data (infarct size comparisons) and effectiveness data (relationship between image quality/confidence ratings and outcomes in a clinical practice setting) suggest moco-LGE is robust. The advantages provided by moco-LGE extend LGE-based risk stratification to include vulnerable patients who may be challenging to image successfully with Figure 6 . Outcomes examining incident hospitalization for heart failure or death according to breath-held segmented late gadolinium enhancement (bh-LGE) or motion-corrected late gadolinium enhancement (moco-LGE) findings. A, Vulnerable patients confirmed by their heart failure/mortality outcomes had significantly decreased image quality in proportion to their vulnerability, and those with the worst event-free survival had bh-LGE imaging abandoned altogether (n=41 of 390) by the supervising CMR physician at the time of the clinical scan (thick line). Thus, bh-LGE image quality was inversely related to patient vulnerability (log-rank, 16.8; P<0.001). B, No such relationship between outcomes and moco-LGE image quality is observed (log-rank, 1.4; P=0.5). C, Abnormality observed on bh-LGE (n=128 of 349) was not able to achieve statistical significance given the omission of the 41 vulnerable individuals in A without bh-LGE image acquisition (log-rank, 3.64; P=0.056). D, Abnormality observed on moco-LGE (n=156 of 390), which included all patients' significantly stratified risk on the entire sample (log-rank, 6.0; P=0.014). Figure 5 . When breath-held segmented late gadolinium enhancement (bh-LGE) image quality was artifact free, scatter plots and Bland-Altman plots show high correlation and excellent agreement across the myocardial infarction size spectrum without evidence of bias (solid and dotted lines indicate mean difference and ±1.96 SD of the differences, respectively). Infarct mass was measured blindly from stacks of short-axis images. Moco-LGE indicates motion-corrected late gadolinium enhancement.
conventional bh-LGE. The moco-LGE technique may be suitable for routine clinical use.
